By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company China Regenerative Medicine International Limited

China Regenerative Medicine International Limited (8158.HK)

HKSE Currency in HKD
$0.77
-$0.02
-2.53%
Last Update: 29 Aug 2025, 10:07
$234.27M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.09 - $1.27
52 Week Range

8158.HK Stock Price Chart

Explore China Regenerative Medicine International Limited interactive price chart. Choose custom timeframes to analyze 8158.HK price movements and trends.

8158.HK Company Profile

Discover essential business fundamentals and corporate details for China Regenerative Medicine International Limited (8158.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

18 Jul 2001

Employees

34.00

CEO

Chuang Wang

Description

China Regenerative Medicine International Limited, an investment holding company, produces and sells healthcare products and services. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.

8158.HK Financial Timeline

Browse a chronological timeline of China Regenerative Medicine International Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 28 Mar 2025

EPS came in at $0.00 , while revenue for the quarter reached $15.42M .

Earnings released on 16 Nov 2024

EPS came in at $0.00 , while revenue for the quarter reached $15.42M .

Earnings released on 24 Aug 2024

EPS came in at $0.03 , while revenue for the quarter reached $29.89M .

Earnings released on 30 Apr 2024

EPS came in at -$0.40 , while revenue for the quarter reached -$42.57M .

Earnings released on 31 Mar 2024

EPS came in at $0.03 , while revenue for the quarter reached $29.89M .

Earnings released on 15 Nov 2023

EPS came in at -$0.02 , while revenue for the quarter reached $11.97M .

Stock split effective on 22 Sept 2023

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 6 Sept 2023

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 23 Aug 2023

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 Aug 2023

EPS came in at $0.04 , while revenue for the quarter reached $46.04M .

Earnings released on 16 May 2023

EPS came in at $0.00 , while revenue for the quarter reached $54.05M .

Earnings released on 11 Apr 2023

EPS came in at -$0.02 , while revenue for the quarter reached $68.47M .

Earnings released on 11 Nov 2022

EPS came in at $0.00 , while revenue for the quarter reached $34.34M .

Earnings released on 30 Sept 2022

EPS came in at $0.00 , while revenue for the quarter reached $76.89M .

Earnings released on 31 Mar 2022

EPS came in at $0.00 , while revenue for the quarter reached $51.92M .

Earnings released on 31 Dec 2021

EPS came in at -$0.00 , while revenue for the quarter reached $82.92M .

Earnings released on 30 Sept 2021

EPS came in at $0.00 , while revenue for the quarter reached $84.67M .

Earnings released on 30 Jun 2021

EPS came in at $0.01 , while revenue for the quarter reached $74.32M .

Earnings released on 31 Mar 2021

EPS came in at -$0.00 , while revenue for the quarter reached $40.98M .

Earnings released on 31 Dec 2020

EPS came in at -$0.12 , while revenue for the quarter reached $61.78M .

Earnings released on 30 Sept 2020

EPS came in at -$0.01 , while revenue for the quarter reached $58.54M .

8158.HK Stock Performance

Access detailed 8158.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run